• Decrease
  • Normal
  • Increase
U.S. Department of Health and Human Services

About FDA

Percentage of new or reformulated infant formula notification reviews completed during the month within 90 days of filing

Dictionary: Timely review of notifications for new and reformulated infant formulas is essential for protecting the health and well being of infants. Since these statutory requirements are notifications rather than pre-market approvals, it is essential that ONLDS have completed review of the information before the submitter markets the product, to notify them of any safety or regulatory concerns before the product reaches consumers.

Information is current as of September 30, 2014.

Fiscal Year - 2013

Skip graphic and jump to text data

TimeAnnual TargetPercentage
Oct 201290100
Nov 201290100
Dec 201290100
Jan 201390100
Feb 201390N/A
Mar 201390100
Apr 201390100
May 201390100
Jun 201390100
Jul 201390100
Aug 201390100
Sep 201390100

FY 2013 Overall: 100%

Number of new or reformulated infant formula notification reviews due to be completed during the month

Fiscal Year - 2013
Skip graphic and jump to text data.

TimeAnnual TargetNumber
Oct 2012N/A2
Nov 2012N/A3
Dec 2012N/A4
Jan 2013N/A0
Feb 2013N/A4
Mar 2013N/A6
Apr 2013N/A1
May 2013N/A1
Jun 2013N/A1
Jul 2013N/A7
Aug 2013N/A2
Sep 2013N/A1

FY 2013 Total: 32

Number of infant formula notification reviews completed during the month within 90 days of filing

Fiscal Year - 2013
Skip graphic and jump to text data.

TimeAnnual TargetNumber
Oct 2012N/A2
Nov 2012N/A3
Dec 2012N/A4
Jan 2013N/A0
Feb 2013N/A4
Mar 2013N/A6
Apr 2013N/A1
May 2013N/A1
Jun 2013N/A1
Jul 2013N/A7
Aug 2013N/A2
Sep 2013N/A1

FY 2013 Total: 32

Total number of infant formula notification reviews completed during the month

Fiscal Year - 2013
Skip graphic and jump to text data.

TimeAnnual TargetNumber
Oct 2012N/A2
Nov 2012N/A3
Dec 2012N/A4
Jan 2013N/A0
Feb 2013N/A4
Mar 2013N/A6
Apr 2013N/A1
May 2013N/A1
Jun 2013N/A1
Jul 2013N/A7
Aug 2013N/A2
Sep 2013N/A1

FY 2013 Total: 32

Glossary

Note: The data provided on this website is produced on an ongoing basis for performance management purposes and is subject to change due to updates of preliminary estimates, corrections, or other reasons. In addition, FDA may change the type or amount of data provided on this website at any time. Information marked as "Completed" may include measures and/or key projects for which activities are ongoing but no longer tracked as part of FDA-TRACK.